Trials / Completed
CompletedNCT00874068
The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants
The Effects of Dietary Palmitic Acid Triacylglyceride Position on Anthropometric Measures, Bone Strength Parameters, Stool Characteristics and Stool Biochemistry in Preterm and Term Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- Enzymotec · Industry
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on bone strength parameters.
Detailed description
InFatTM is an advanced basic-fat ingredient, which mimics the fat composition and properties of human milk fat and enabling optimal intake of the essential calcium and energy (in the form of fatty acids) and easy digestion. These benefits are the results of a unique fatty acid composition on the glycerol backbone, which ensure high level of palmitic acid at the middle (sn-2) position. The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on bone strength parameters, anthropometric parameters, wellbeing and stool characteristics in term and preterm infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | InFat™ based infant formula | high sn-2 palmitic acid oil based infant formula |
| OTHER | Standard vegetable oil based infant formula | standard vegetable oil based infant formula |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-04-02
- Last updated
- 2011-02-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00874068. Inclusion in this directory is not an endorsement.